Category Archives: FDA Stem Cell Trials

Trevor Raborn founded UaretheCURE to help recruit donors for an FDA Approved Clinical Cancer Trial. Originally posted here: A Thank You For Trevor Raborn … Continue reading →

CBLB502 was granted Fast Track and Orphan Drug designations from the FDA for reducing the risk of or preventing death following total body irradiation during or after radiation disaster. The FDA Fast Track program is designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Such programs include expanded communications (both verbal and written), rolling BLA submission and reviews, priority review (6 month action date instead of 10 month action date) and accelerated drug approval (approval on the basis of a surrogate endpoint). View post: CBLI Breaking News … Continue reading →

A Decade with the Human Genome Sequence: Charting a Course for Genomic Medicine NHGRI hosted a day-long scientific symposium on Friday, Feb. 11, 2011, 8:30 am - 5:00 pm at the Ruth L. Here is the original post: Anticipating the Next Decade of the Genome - Francis Collins, Director of NIH … Continue reading →

Listen in as leading pediatric neurosurgeon Dr. Baumgartner discusses the future potential of regenerative medicine. Cord blood stem cells are being used today to treat blood disorders and certain cancers. Follow this link: What is Cord Blood Banking? The Medical Potential of Newborn Stem Cells … Continue reading →

CNN's Dr. Sanjay Gupta reports on a new stem cell clinical trial that is making history. More: Stem cell medical breakthrough? … Continue reading →

Yu-Chong Tai, Director, Caltech Micro Machining Laboratory, California Institute of Technology discusses research in the use of neural implants such pacemakers and electronic cochlear implants. Dr. Tai reviews progress on the next generation of implants which must be miniature, flexible, and highly functional for muscular, retinal, cortical, and spinal use. Continued here: NIST Colloquium Series: Next Generation Neural Implants … Continue reading →

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials. Excerpt from: Alan Lewis: Embryonic Stem Cell Therapies for diabetes … Continue reading →

Dr Lanza of ACT explains upcomming therpaies of blood generation and vascular repair using stem cells. Their cell were extracted from a single cell without destroying the embryo More here: ACT - Dr Lanza - Hermangioblast program - Advanced cell technology … Continue reading →

KXAN covered the August 16th Learn for Life education event at LIVESTRONG HQ hosted by Texans for Stem Cell Research (TSCR). TSCR provides the public the opportunity to learn about groundbreaking research in stem cell science with the assistance of volunteers, leading academicians, researchers, industry leaders and advocates from around the world. The events attract highly respected stem cell research professionals who provide the most current findings in their field to promote awareness for important FDA approved clinical trials that have the potential to aid the development of new treatments for unmet medical needs Originally posted here: Texans for Stem Cell Research Learn for Life: KXAN Coverage Aired August 16th, 2011 … Continue reading →

Bill Caldwell, Chairman Read the original: Bill Caldwell, Chairman … Continue reading →